Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Ekso Bionics Holdings (EKSO) EBIAT (2016 - 2025)

Historic EBIAT for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' EBIAT rose 3141.89% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.4 million, marking a year-over-year increase of 626.18%. This contributed to the annual value of -$11.3 million for FY2024, which is 2545.07% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its EBIAT stood at -$1.4 million for Q3 2025, which was up 3141.89% from -$2.7 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' EBIAT peaked at -$1.3 million during Q2 2021, and registered a low of -$4.6 million during Q1 2022.
  • For the 5-year period, Ekso Bionics Holdings' EBIAT averaged around -$3.1 million, with its median value being -$3.2 million (2022).
  • Over the last 5 years, Ekso Bionics Holdings' EBIAT had its largest YoY gain of 8918.16% in 2021, and its largest YoY loss of 17985.32% in 2021.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' EBIAT stood at -$2.9 million in 2021, then fell by 11.0% to -$3.2 million in 2022, then decreased by 1.13% to -$3.2 million in 2023, then fell by 6.19% to -$3.4 million in 2024, then soared by 58.37% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$2.7 million for Q2 2025, and -$2.9 million during Q1 2025.